Russell Investments Group Ltd. Raises Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Russell Investments Group Ltd. boosted its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 83.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 53,522 shares of the company’s stock after purchasing an additional 24,375 shares during the quarter. Russell Investments Group Ltd.’s holdings in Doximity were worth $2,858,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in DOCS. Global Retirement Partners LLC boosted its stake in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. grew its stake in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Larson Financial Group LLC increased its holdings in Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after buying an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new stake in Doximity during the fourth quarter valued at approximately $43,000. Finally, Morse Asset Management Inc acquired a new position in shares of Doximity in the 3rd quarter worth approximately $46,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 37.40% of the company’s stock.

Doximity Trading Up 0.6 %

Doximity stock opened at $53.10 on Friday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The stock has a market cap of $9.91 billion, a price-to-earnings ratio of 53.10, a PEG ratio of 4.10 and a beta of 1.41. The company’s 50-day moving average price is $63.40 and its two-hundred day moving average price is $55.67.

Analysts Set New Price Targets

DOCS has been the topic of several research reports. Raymond James reissued an “outperform” rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. KeyCorp dropped their target price on shares of Doximity from $83.00 to $70.00 and set an “overweight” rating on the stock in a report on Wednesday. Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $31.00 to $78.00 in a report on Friday, February 7th. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Finally, The Goldman Sachs Group raised their target price on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $65.00.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.